These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

603 related items for PubMed ID: 27157848

  • 1. A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia.
    Gray B, Bagnall RD, Lam L, Ingles J, Turner C, Haan E, Davis A, Yang PC, Clancy CE, Sy RW, Semsarian C.
    Heart Rhythm; 2016 Aug; 13(8):1652-60. PubMed ID: 27157848
    [Abstract] [Full Text] [Related]

  • 2.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Napolitano C, Mazzanti A, Bloise R, Priori SG.
    ; 1993 Aug. PubMed ID: 20301466
    [Abstract] [Full Text] [Related]

  • 3. Genetic characterization of familial CPVT after 30 years.
    Beery TA, Shah MJ, Benson DW.
    Biol Res Nurs; 2009 Jul; 11(1):66-72. PubMed ID: 19398417
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of CASQ2-Catecholaminergic Polymorphic Ventricular Tachycardia.
    Ng K, Titus EW, Lieve KV, Roston TM, Mazzanti A, Deiter FH, Denjoy I, Ingles J, Till J, Robyns T, Connors SP, Steinberg C, Abrams DJ, Pang B, Scheinman MM, Bos JM, Duffett SA, van der Werf C, Maltret A, Green MS, Rutberg J, Balaji S, Cadrin-Tourigny J, Orland KM, Knight LM, Brateng C, Wu J, Tang AS, Skanes AC, Manlucu J, Healey JS, January CT, Krahn AD, Collins KK, Maginot KR, Fischbach P, Etheridge SP, Eckhardt LL, Hamilton RM, Ackerman MJ, Noguer FRI, Semsarian C, Jura N, Leenhardt A, Gollob MH, Priori SG, Sanatani S, Wilde AAM, Deo RC, Roberts JD.
    Circulation; 2020 Sep 08; 142(10):932-947. PubMed ID: 32693635
    [Abstract] [Full Text] [Related]

  • 7. CASQ2 variants in Chinese children with catecholaminergic polymorphic ventricular tachycardia.
    Li Q, Guo R, Gao L, Cui L, Zhao Z, Yu X, Yuan Y, Xu X.
    Mol Genet Genomic Med; 2019 Nov 08; 7(11):e949. PubMed ID: 31482657
    [Abstract] [Full Text] [Related]

  • 8. Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights.
    Kontula K, Laitinen PJ, Lehtonen A, Toivonen L, Viitasalo M, Swan H.
    Cardiovasc Res; 2005 Aug 15; 67(3):379-87. PubMed ID: 15913575
    [Abstract] [Full Text] [Related]

  • 9. Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond.
    Katz G, Arad M, Eldar M.
    Curr Probl Cardiol; 2009 Jan 15; 34(1):9-43. PubMed ID: 19068246
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia.
    Khoury A, Marai I, Suleiman M, Blich M, Lorber A, Gepstein L, Boulos M.
    Heart Rhythm; 2013 Nov 15; 10(11):1671-5. PubMed ID: 23954267
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia.
    Song L, Alcalai R, Arad M, Wolf CM, Toka O, Conner DA, Berul CI, Eldar M, Seidman CE, Seidman JG.
    J Clin Invest; 2007 Jul 15; 117(7):1814-23. PubMed ID: 17607358
    [Abstract] [Full Text] [Related]

  • 15. A case of catecholaminergic polymorphic ventricular tachycardia caused by two calsequestrin 2 mutations.
    de la Fuente S, Van Langen IM, Postma AV, Bikker H, Meijer A.
    Pacing Clin Electrophysiol; 2008 Jul 15; 31(7):916-9. PubMed ID: 18684293
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Genetic background of catecholaminergic polymorphic ventricular tachycardia in Japan.
    Kawamura M, Ohno S, Naiki N, Nagaoka I, Dochi K, Wang Q, Hasegawa K, Kimura H, Miyamoto A, Mizusawa Y, Itoh H, Makiyama T, Sumitomo N, Ushinohama H, Oyama K, Murakoshi N, Aonuma K, Horigome H, Honda T, Yoshinaga M, Ito M, Horie M.
    Circ J; 2013 Jul 15; 77(7):1705-13. PubMed ID: 23595086
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Catecholaminergic polymorphic ventricular tachycardia.
    Liu N, Colombi B, Raytcheva-Buono EV, Bloise R, Priori SG.
    Herz; 2007 May 15; 32(3):212-7. PubMed ID: 17497254
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.